SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SK Chemicals Co Ltd (006120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3436
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance resins which include skybon, chemicals for electronics, skyviva, skynova, skyflex, SK compound, and ecotran. The company offers biomaterials such as ecoprime and ecoplan. It also provides new synthetic and botanical drugs, and vaccines. The company has operations in South Korea, the US, China, Japan, Korea, Germany and Singapore. SK Chemicals is headquartered in Gyeonggi-do, South Korea.

SK Chemicals Co Ltd (006120) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 10
SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811 11
SK Chemicals and International Vaccine Institute Enters into Agreement 12
SK Chemicals Enters Into Co-Development Agreement With DNA Link 13
Licensing Agreements 14
Sanofi Pasteur Enters into Licensing Agreement with SK Chemicals 14
Hikma Pharma Enters into Licensing Agreement with SK Chemicals 15
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 16
SK Chemicals Co Ltd – Key Competitors 17
SK Chemicals Co Ltd – Key Employees 18
SK Chemicals Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Product News 21
01/09/2017: AFSTYLA, for Haemophilia A, Receives European Commission Approval 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 10
SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811 11
SK Chemicals and International Vaccine Institute Enters into Agreement 12
SK Chemicals Enters Into Co-Development Agreement With DNA Link 13
Sanofi Pasteur Enters into Licensing Agreement with SK Chemicals 14
Hikma Pharma Enters into Licensing Agreement with SK Chemicals 15
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 16
SK Chemicals Co Ltd, Key Competitors 17
SK Chemicals Co Ltd, Key Employees 18
SK Chemicals Co Ltd, Other Locations 19
SK Chemicals Co Ltd, Subsidiaries 19
SK Chemicals Co Ltd, Joint Venture 20

List of Figures
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • NCC AB:企業の戦略・SWOT・財務情報
    NCC AB - Strategy, SWOT and Corporate Finance Report Summary NCC AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • OGE Energy Corp (OGE):企業の財務・戦略的SWOT分析
    OGE Energy Corp (OGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Wistar Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training. The institute performs research in the areas of cancer, infectious diseases, immunology and vaccine development. It also conducts research on genes, gene expression, and DNA biolo …
  • Mercury Systems, Inc.:企業のM&A・事業提携・投資動向
    Mercury Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercury Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Shenogen Pharma Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shenogen Pharma Group Ltd (Shenogen) is a drug discovery and development company that develops therapeutics for cancer treatment. The company develops biologic drugs and small molecule targeted at the new estrogen receptor variant. It provides SNG-162 that is a small molecule naturally deriv …
  • Translate Bio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • TranSystems Corporation:企業の戦略・SWOT・財務情報
    TranSystems Corporation - Strategy, SWOT and Corporate Finance Report Summary TranSystems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ITOCHU Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    ITOCHU Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Herstal SA:企業の戦略・SWOT・財務情報
    Herstal SA - Strategy, SWOT and Corporate Finance Report Summary Herstal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Murata Manufacturing Co., Ltd.:企業の戦略・SWOT・財務分析
    Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Dynatronics Corp (DYNT):医療機器:M&Aディール及び事業提携情報
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and r …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pharmaxis Ltd (PXS)-製薬・医療分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • China Singyes Solar Technologies Holdings Limited (750):電力:M&Aディール及び事業提携情報
    Summary China Singyes Solar Technologies Holdings Limited (Singyes Solar) is a provider of renewable energy solutions and building contractor. It carries out the design, fabrication and installation of conventional curtain walls, green building and solar projects. Its solar EPC activities specialize …
  • Sandoz Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sandoz Inc (Sandoz), a division of Novartis AG (Novartis), is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars. The company also provides intermediary products including active pharmaceutical …
  • Finsbury Food Group PLC (FIF):企業の財務・戦略的SWOT分析
    Summary Finsbury Food Group PLC (Finsbury) is a manufacturer and supplier of bakery products. The company offers cake products such as party cakes, seasonal and festive cakes; premium cakes, kids' cakes, triple-layer cakes, loaf cakes, crumble cakes, tiffin, mini and giant rolls, roulades, rocky roa …
  • Neurelis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company's product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult p …
  • Medibank Private Limited (MPL):企業の財務・戦略的SWOT分析
    Medibank Private Limited (MPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆